(Q46853343)
Statements
1 reference
Deviating from safety guidelines during deferiprone therapy in clinical practice may not be associated with higher risk of agranulocytosis (English)
1 reference
Mohssen Elalfy
1 reference
Yasser A Wali
1 reference
Mohamad Qari
1 reference
Ghazi Al Damanhouri
1 reference
Youssef Al-Tonbary
1 reference
Dilek Yazman
1 reference
Zakaria Al Hawsawi
1 reference
Zeynep Karakas
1 reference
Yurdanur Kilinc
1 reference
M Akif Yesilipek
1 reference
Mohamed Badr
1 reference
Usama Elsafy
1 reference
Mostafa Salama
1 reference
Yousryeia Abdel Rahman
1 reference
Shebl Shebl
1 reference
Anne Stilman
1 reference
Noemi Toiber Temin
1 reference
Fernando Tricta
1 reference
30 December 2013
1 reference
61
1 reference
5
1 reference
879-884
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference